Search | VHL Regional Portal

Meeting notes from the 3rd IAS Conference. New drugs.

Feinberg, Judith.

AIDS Clin Care ; 17(10): 96-7, 2005 Oct.

Article in English | MEDLINE | ID: mdl-16276591

ABSTRACT

CCR5 antagonists created quite a buzz at IAS: several are entering phase III trials and could be available in the next 2 to 3 years.

Subject(s)

CCR5 Receptor Antagonists , Congresses as Topic , Brazil , Cytidine Triphosphate/administration & dosage , Cytidine Triphosphate/analogs & derivatives , Cytidine Triphosphate/therapeutic use , Darunavir , HIV Infections/drug therapy , Reverse Transcriptase Inhibitors/administration & dosage , Reverse Transcriptase Inhibitors/therapeutic use , Sulfonamides/administration & dosage , Sulfonamides/therapeutic use , Zalcitabine/analogs & derivatives

See more details

SEND TO:

Export

RSS

XML

SELECTION OF CITATIONS

List items (0)
Clear list

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL